A PYMNTS Company

JUL-12(2)

BY | December 21, 2015

The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to pharm.; in particular, at the Italian…

The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to pharm.; in particular, at the Italian Pfizer case, the Boehringer decision, and court developments since Astra-Zeneca: Is there a pattern? Back in the U.S. we wonder if K-Dur will force the Supreme Court to look at reverse payments. And for a series wrap-up we ask, “Should policy focus on reducing health care costs?” Finally, taking a breather from health car

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.215.16.238

Please verify email or join us to access premium content!